Your browser doesn't support javascript.
loading
DUX4 expression activates JNK and p38 MAP kinases in myoblasts.
Brennan, Christopher M; Hill, Abby S; St Andre, Michael; Li, Xianfeng; Madeti, Vijaya; Breitkopf, Susanne; Garren, Seth; Xue, Liang; Gilbert, Tamara; Hadjipanayis, Angela; Monetti, Mara; Emerson, Charles P; Moccia, Robert; Owens, Jane; Christoforou, Nicolas.
  • Brennan CM; Rare Disease Research Unit, Pfizer Inc., Cambridge, MA 02139, USA.
  • Hill AS; WRDM Postdoctoral Program, Pfizer Inc., Cambridge, MA 02139, USA.
  • St Andre M; Rare Disease Research Unit, Pfizer Inc., Cambridge, MA 02139, USA.
  • Li X; Rare Disease Research Unit, Pfizer Inc., Cambridge, MA 02139, USA.
  • Madeti V; Rare Disease Research Unit, Pfizer Inc., Cambridge, MA 02139, USA.
  • Breitkopf S; NGS Technology Center, Inflammation and Immunology Research Unit, Pfizer, Cambridge, MA 02139, USA.
  • Garren S; Proteomics Technology Center, Internal Medicine Research Unit, Pfizer, Cambridge, MA 02139, USA.
  • Xue L; NGS Technology Center, Inflammation and Immunology Research Unit, Pfizer, Cambridge, MA 02139, USA.
  • Gilbert T; Machine Learning and Computational Science, Pfizer Inc., Cambridge, MA 02139, USA.
  • Hadjipanayis A; High Content Imaging Technology Center, Internal Medicine Research Unit, Pfizer, Cambridge, MA 02139, USA.
  • Monetti M; NGS Technology Center, Inflammation and Immunology Research Unit, Pfizer, Cambridge, MA 02139, USA.
  • Emerson CP; Proteomics Technology Center, Internal Medicine Research Unit, Pfizer, Cambridge, MA 02139, USA.
  • Moccia R; Rare Disease Research Unit, Pfizer Inc., Cambridge, MA 02139, USA.
  • Owens J; Wellstone Muscular Dystrophy Program, Department of Neurology, University of Massachusetts Medical School, Worcester, MA 01655, USA.
  • Christoforou N; Rare Disease Research Unit, Pfizer Inc., Cambridge, MA 02139, USA.
Dis Model Mech ; 15(11)2022 11 01.
Article en En | MEDLINE | ID: mdl-36196640
ABSTRACT
Facioscapulohumeral muscular dystrophy (FSHD) is caused by misexpression of the DUX4 transcription factor in skeletal muscle that results in transcriptional alterations, abnormal phenotypes and cell death. To gain insight into the kinetics of DUX4-induced stresses, we activated DUX4 expression in myoblasts and performed longitudinal RNA sequencing paired with proteomics and phosphoproteomics. This analysis revealed changes in cellular physiology upon DUX4 activation, including DNA damage and altered mRNA splicing. Phosphoproteomic analysis uncovered rapid widespread changes in protein phosphorylation following DUX4 induction, indicating that alterations in kinase signaling might play a role in DUX4-mediated stress and cell death. Indeed, we demonstrate that two stress-responsive MAP kinase pathways, JNK and p38, are activated in response to DUX4 expression. Inhibition of each of these pathways ameliorated DUX4-mediated cell death in myoblasts. These findings uncover that the JNK pathway is involved in DUX4-mediated cell death and provide additional insights into the role of the p38 pathway, a clinical target for the treatment of FSHD.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Distrofia Muscular Facioescapulohumeral Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Distrofia Muscular Facioescapulohumeral Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article